CAF regimen
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]
Synonyms and keywords: CAF; CAFFI; CAF Regimen; CDF; CTX/DOX/5-FU; Cyclophosphamide-Adriamycin-Fluorouracil Regimen; Cyclophosphamide/Doxorubicin/Fluorouracil; FAC
Overview
Overview
CAF regimen refers to a chemotherapy regimen consisting of cyclophosphamide, doxorubicin hdrochloride (Adriamycin), and fluorouracil, which may be used in the adjuvant setting for the treatment of nonmetastatic breast cancer or alone for the treatment of metastatic breast cancer.[1][2]
Regimen
Regimen
CCyclophosphamide
ADoxorubicin (Adriamycin)
FFluorouracil
References
References
- ↑ “NCI Thesaurus”.
- ↑ “R-CHOP – National Cancer Institute”.
- ↑ Khaloozadeh H, Yazdanbakhsh P, Homaei-shandiz F (2008). “The optimal dose of CAF regimen in adjuvant chemotherapy for breast cancer patients at stage IIB”. Math Biosci. 213 (2): 151–8. doi:10.1016/j.mbs.2008.04.003. PMID 18533195.
Looking for the patient version?
© 2026 MyEClinic – IFTM Institut für Telematik in der Medizin GmbH
